|1.||Thyroid Diseases (Thyroid Disease)
|3.||Kidney Diseases (Kidney Disease)
|5.||Hypertension (High Blood Pressure)
|1.||Inaba, Masaaki: 5 articles (01/2012 - 01/2004)|
|2.||Imanishi, Yasuo: 4 articles (01/2012 - 10/2007)|
|3.||Kawata, Takehisa: 3 articles (10/2009 - 10/2007)|
|4.||Nishizawa, Yoshiki: 3 articles (10/2009 - 10/2007)|
|5.||Krysiak, Robert: 2 articles (01/2015 - 01/2014)|
|6.||Okopień, Bogusław: 2 articles (01/2015 - 01/2014)|
|7.||Henry, Jean-François: 2 articles (11/2011 - 09/2008)|
|8.||Vriens, Menno R: 2 articles (04/2011 - 01/2011)|
|9.||Borel Rinkes, Inne H M: 2 articles (04/2011 - 01/2011)|
|10.||Minard, Gayle: 2 articles (06/2007 - 05/2004)|
04/01/1993 - "In conclusion, we believe that the PTH-calcium curve provides a reliable assessment of parathyroid function, and as such, has considerable application for the study of parathyroid disorders in the clinical setting."
12/01/2011 - "Disorders of calcium metabolism and parathyroid disease."
07/01/2000 - "Parathyroid disease and calcium metabolism."
09/18/1999 - "DISEASE STATES: Mutations affecting the calcium receptor sequence cause hereditary or familial parathyroid diseases. "
02/01/1998 - "A single diseased gland was found in 27 patients with PTS, which is in favour of primary parathyroid disease, being responsible for, and not a consequence of, PTS. Only the serum calcium (13.0 vs 12.1 g/dL) level was significantly increased in PHPT patients with PTS, when compared to those without PTS. The calcium level is probably of major importance in the development of PTS, which was never encountered in 211 patients with RHPT, who had low calcium and high PTH levels. "
|2.||Parathyroid Hormone (Parathormone)IBA
01/01/2009 - "Recent findings in the use of intraoperative parathyroid hormone monitoring in parathyroid disease."
01/01/2008 - "Important recent advancements in the field of parathyroid disease include improvements in preoperative localization, the use of intraoperative parathyroid hormone monitoring, and the development of minimally invasive and videoscopic surgical techniques. "
04/01/2007 - "The purpose of this review is to provide the surgeon with the practical points and pitfalls of the use of intraoperative parathyroid hormone in the treatment of parathyroid disease."
02/01/2004 - "Impact of intraoperative parathyroid hormone monitoring on the prediction of multiglandular parathyroid disease."
05/01/2002 - "Recent advances in parathyroid disease and parathyroid hormone assays."
|3.||Coarctation of the aortaIBA
11/01/2011 - "The aim of the present study was to evaluate the variable findings of lithium-associated parathyroid disease. "
01/01/2015 - "The described case suggests that patients with pre-existing parathyroid disorders may be particularly susceptible to the development of lithium-induced hyperparathyroidism."
01/01/2014 - " described case suggests that patients with preexisting parathyroid disorders may be particularly susceptible to the development of lithium-induced hyperparathyroidism."
01/01/2014 - "BNE in patients with pHPT is the preferred surgical technique in the following circumstances: a suspicion of multiglandular parathyroid disease (MEN 1 or 2A syndrome, familial hyperparathyroidism, lithium therapy), a negative preoperative imaging, in patients not consenting for MIP, and in cases with concomitant goitre necessitating surgical treatment. "
03/01/2000 - "19-nor-1alpha,25(OH)2D2, an analogue of 1alpha,25(OH)2D3 that was originally developed for the treatment of parathyroid disease, has been shown to be less calcemic than 1alpha,25(OH)2D3 in clinical trials. "
06/01/1996 - "These patients had severe parathyroid disease and low levels of 25(OH) vitamin D before operation. "
02/01/2013 - "Vignettes contained patient characteristics including light vs dark skin, CKD stage, cause of renal disease, parathyroid hormone (PTH), and 25(OH) vitamin D levels. "
02/01/1981 - "In order to clarify the complex interrelationship between serum calcium, 1,25-dihydroxyvitamin D (1,25(OH)2D), and parathyroid hormone (PTH), and the urinary excretion of cyclic AMP (cAMP) in response to exogenous PTH in pseudohypoparathyroidism (PHP) and related diseases, we investigated 3 patients with parathyroid disorders before and after treatment with 1 alpha-hydroxyvitamin D3 (1 alpha-OH-D3). "
|6.||Brain Natriuretic Peptide (Natrecor)FDA Link
|10.||pro-brain natriuretic peptide (1-76)IBA
12/01/2006 - "Cure of the parathyroid disease is followed by a further increase in NT-proBNP secretion in parallel with ERNA measures, indicating subclinical changes in heart function. "
12/01/2006 - "The aims of the present study were to evaluate how cardiac function and secretion of N-terminal pro-B-type natriuretic peptide (NT-proBNP) correlate in patients with mild PHPT, and how the plasma level of NT-proBNP is influenced by cure of the parathyroid disease. "
06/01/2011 - "Targeted parathyroidectomy is the gold standard for localized parathyroid disease. "
11/01/2012 - "The introduction of various techniques for minimally invasive parathyroidectomy (MIP) has changed both the conceptual and surgical approach to parathyroid disease. "
09/01/2012 - "Searching strategy was based on diagnoses of parathyroid disease and patients undergoing parathyroidectomy across all UHC member facilities. "
04/01/2011 - "The advent of minimally invasive parathyroidectomy (MIP), aiming at a preoperatively identified parathyroid abnormality may be associated with a different incidence of solitary and multiglandular parathyroid disease. "
07/01/1998 - "This article deals with parathyroid disease and parathyroidectomy. "
02/01/2015 - "Nineteen patients with thyroidectomy, 20 patients with thyroparathyroidectomy, and 20 controls with no history of thyroid or parathyroid disease or surgery were included in the study. "
01/01/2014 - "A total of 452 consecutive patients with thyroid and parathyroid disease underwent endoscopic thyroidectomy via a breast approach at Uijeongbu St. Mary's Hospital between November 1999 and December 2012. "
10/01/2010 - "Thirteen patients (4% of all patients) underwent a thyroid operation not related to parathyroid disease: 9 thyroid lobectomies for presumably benign nodules and 4 total thyroidectomies for malignancy. "
10/01/1981 - "Parathyroid autotransplantation in patients with parathyroid disease and total thyroidectomy. "
09/01/1981 - "Unexpected parathyroid disease discovered at thyroidectomy in irradiated patients."
12/01/1972 - "Parathyroid disease in the transplant patient."
05/01/1999 - "The spectrum of parathyroid disease demonstrated with Tc-99m sestamibi scintigraphy includes eutopic disease, ectopic disease, solitary adenoma, double or multiple adenomas, cystic adenoma, lipoadenoma, multiple endocrine neoplasia, hyperfunctioning parathyroid transplant, entities with atypical washout, and nonparathyroid entities that take up Tc-99m sestamibi. "
08/01/2010 - "Insofar as the CaSR is a clinically important therapeutic target for parathyroid disorders, development of its agonists or antagonists as therapeutics for CNS disorder could be a major breakthrough."
07/01/2009 - "This review discusses the molecular pathogenesis of hyperfunctioning parathyroid diseases and the applications of animal models exhibiting hyperparathyroidisms in the aspect of the development of new therapeutics. "
|5.||Drug Therapy (Chemotherapy)
09/01/2008 - "Overall, using the combined scintigraphic/USG single-day protocol, in the thyroid diseases group the therapeutic strategy (drug therapy vs radioiodine therapy vs surgery) was changed in 176/225 patients (78.2%, P<0.001 by chi(2) of Pearson), and in the parathyroid disease group the therapeutic strategy (medical therapy vs surgery) was changed in 18/48 patients (37.5%, P<0.01 by chi2 test of Pearson). "
08/01/1977 - "A history of nephrolithiasis and hypercalcemia preceding the institution of drug therapy allowed this patient's underlying parathyroid disease to be defined as primary hyperparathyroidism, which had been obscured by anticonvulsant therapy."